Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):  
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    OA03 - Immunotherapy Checkpoint Inhibitors in Advanced NSCLC

    • Type: Oral Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 8
    • Moderators:L. Crinò
    • Coordinates: 12/05/2016, 11:00 - 12:30, Hall C8
    • +

      OA03.07 - KEYNOTE-010: Durable Clinical Benefit in Patients with Previously Treated, PD-L1-Expressing NSCLC Who Completed Pembrolizumab 

      12:05 - 12:15  |  Author(s): R. Herbst

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    SC05 - Novel Drugs in Thoracic Cancers

    • Type: Science Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 5
    • Moderators:R. Herbst
    • Coordinates: 12/05/2016, 11:00 - 12:30, Hall C2
  • +

    P1.05 - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Early Stage NSCLC
    • Presentations: 79
    • Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P1.05-017 - The Prognostic Impact of EGFR, KRAS and TP53 Somatic Mutations in Curatively Resected Early-Stage Lung Adenocarcinomas

      14:30 - 14:30  |  Author(s): B.E. Gould Rothberg

      • Abstract

      Loading...

  • +

    SC14 - Immunotherapy of NSCLC

    • Type: Science Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 5
    • Moderators:N. Rizvi
    • Coordinates: 12/06/2016, 11:00 - 12:30, Hall C2
  • +

    P2.01 - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Biology/Pathology
    • Presentations: 94
    • Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P2.01-046 - Quantitative Measurement of B7-H3 Protein Expression and Its Association with B7-H4, PD-L1 and TILs in NSCLC

      14:30 - 14:30  |  Author(s): M. Altan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.03b - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 98
    • Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P2.03b-053 - Role of KRAS Mutation Status in NSCLC Patients Treated on SWOG S0819, a Phase III Trial of Chemotherapy with or without Cetuximab

      14:30 - 14:30  |  Author(s): P. Mack

      • Abstract

      Loading...

  • +

    MA15 - Immunotherapy Prediction

    • Type: Mini Oral Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 12
    • Moderators:O. Arrieta
    • Coordinates: 12/07/2016, 14:20 - 15:50, Schubert 1
    • +

      MA15.06 - Predictive Value of Measuring Somatic Mutations and Tumor Infiltrating Lymphocytes for PD-1 Axis Therapy in Non-Small Cell Lung Cancer (NSCLC)

      14:56 - 15:02  |  Author(s): S.N. Gettinger

      • Abstract

      Loading...

  • +

    MA16 - Novel Strategies in Targeted Therapy

    • Type: Mini Oral Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 12
    • Moderators:G. Purkalne
    • Coordinates: 12/07/2016, 14:20 - 15:50, Strauss 2
  • +

    P3.02c - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 103
    • Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P3.02c-042 - IMpower110: Phase III Trial Comparing 1L Atezolizumab with Chemotherapy in PD-L1–Selected Chemotherapy-Naive NSCLC Patients

      14:30 - 14:30  |  Author(s): F. De Marinis

      • Abstract

      Loading...

    • +

      P3.02c-048 - A Phase I/II Trial Evaluating the Combination of Stereotactic Body Radiotherapy and Pembrolizumab in Metastatic NSCLC

      14:30 - 14:30  |  Author(s): R.H. Decker

      • Abstract

      Loading...

    • +

      P3.02c-070 - Combination Immunotherapy with MEK Inhibitor for Treatment of Kras-Mutant Lung Cancer in Animal Model

      14:30 - 14:30  |  Author(s): J.W. Lee

      • Abstract

      Loading...

    • +

      P3.02c-088 - Acquired Resistance to Programmed Death-1 Axis Inhibitors in Non-Small Cell Lung Cancer (NSCLC)

      14:30 - 14:30  |  Author(s): J. Choi

      • Abstract

      Loading...